| abstract |
Methods for modulating immune responses in an antigen-specific fashion are disclosed. The methods utilize soluble TCR.alpha. chains which are capable of binding to the antigen, and which, in the presence of an accessory component, suppress the immune response in an antigen-specific manner. The use of TCR.alpha. chains which demonstrate such activity in therapeutic protocols for treating hyperimmune and immunodeficient conditions is described. |